Pharmacokinetics of BPV Following Bilateral US-guided TAP Block for C-section

NCT03006042 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2016-12-30

No results posted yet for this study

Summary

The transversus abdominis plane block (TAP block) is an effective method of postoperative pain management after cesarean section (C-section). Up to now, there are no data available about bupivacaine (BPV) plasma levels after TAP block in adults. In the current study, the investigators aimed to assess BPV pharmacokinetic parameters after ultrasound-guided TAP block using BPV in parturients undergoing C-section and to report its effects on corrected QT interval.

Conditions

  • Anesthesia
  • Adverse Effect
  • Cesarean Section
  • Transversus Abdominis Plane Block

Interventions

DRUG

Bupivacaine

Sponsors & Collaborators

  • University Tunis El Manar

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03006042 on ClinicalTrials.gov